Related references
Note: Only part of the references are listed.Liquid biopsies: Potential and challenges
Isabel Heidrich et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection
Marc Hirschfeld et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2-postmenopausal breast cancer patients treated with everolimus and exemestane
Dinja T. Kruger et al.
MOLECULAR ONCOLOGY (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
Xiaoqiu Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
Francesco Pantano et al.
SCIENTIFIC REPORTS (2020)
The function and clinical application of extracellular vesicles in innate immune regulation
Xiaoxue Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation
Min-Sun Cho et al.
PLOS ONE (2020)
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis
Guobin Zhong et al.
ONCOTARGETS AND THERAPY (2020)
Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing
Timour Baslan et al.
ELIFE (2020)
Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities
Zeina Habli et al.
CANCERS (2020)
Technologies and Standardization in Research on Extracellular Vesicles
Srujan Gandham et al.
TRENDS IN BIOTECHNOLOGY (2020)
Exosomes: A Source for New and Old Biomarkers in Cancer
Mariantonia Logozzi et al.
CANCERS (2020)
Exosomes as a Multicomponent Biomarker Platform in Cancer
Valerie S. LeBleu et al.
TRENDS IN CANCER (2020)
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Olga Martinez-Saez et al.
BREAST CANCER RESEARCH (2020)
Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study
Gaetan Chanteloup et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Exosomes: key players in cancer and potential therapeutic strategy
Jie Dai et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Application of exosomes as liquid biopsy in clinical diagnosis
Biting Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Elisabeth Trapp et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Agreement between digital breast tomosynthesis and pathologic tumour size for staging breast cancer, and comparison with standard mammography
M. Luke Marinovich et al.
BREAST (2019)
Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
Yiming Meng et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Raoul Charles Coombes et al.
CLINICAL CANCER RESEARCH (2019)
Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients
Shicong Tang et al.
JOURNAL OF BIOSCIENCES (2019)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Technologies for circulating tumor cell separation from whole blood
Petra Banko et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Mechanisms associated with biogenesis of exosomes in cancer
Kathleen M. McAndrews et al.
MOLECULAR CANCER (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
Marzia Del Re et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
Areti Strati et al.
CELLS (2019)
Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis
Ben O'Leary et al.
CLINICAL CHEMISTRY (2019)
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Bradon R. McDonald et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
Fabienne Schochter et al.
CELLS (2019)
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
Zhong Ye et al.
EUROPEAN JOURNAL OF CANCER (2019)
Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer
Xiaodan Wang et al.
MOLECULAR CARCINOGENESIS (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance
Daniel Stetson et al.
JCO PRECISION ONCOLOGY (2019)
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
Arielle J. Medford et al.
NPJ PRECISION ONCOLOGY (2019)
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Alba Rodriguez-Martinez et al.
BREAST CANCER RESEARCH (2019)
Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
Stamatia Rontogianni et al.
COMMUNICATIONS BIOLOGY (2019)
Exosomal lncRNAs: the newest promising liquid biopsy
Marta Tellez-Gabriel et al.
CANCER DRUG RESISTANCE (2019)
Circulating tumor cell isolation, culture, and downstream molecular analysis
Sandhya Sharma et al.
BIOTECHNOLOGY ADVANCES (2018)
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)
Mark Jesus M. Magbanua et al.
CLINICAL CANCER RESEARCH (2018)
被撤回的出版物: Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer (Retracted article. See vol. 61, 2022)
Huaying Dong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Circulating Tumor DNA Assays in Clinical Cancer Research
Miguel R. Ossandon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer
Mio Yoshikawa et al.
ONCOLOGY LETTERS (2018)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Francois-Clement Bidard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Circulating Tumor DNA Assays in Clinical Cancer Research
Miguel R. Ossandon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer
Chelain R. Goodman et al.
JAMA ONCOLOGY (2018)
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Ines Stevic et al.
BMC MEDICINE (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
Joseph Sparano et al.
JAMA ONCOLOGY (2018)
Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
Veronika Vymetalkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
Yi-Long Wu et al.
LUNG CANCER (2018)
The Value of Monitoring the Behavior of Circulating Tumor Cells at the End of Endocrine Therapy in Breast Cancer Patients
Katharina Pachmann et al.
CANCERS (2018)
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial
Anna-Maria Larsson et al.
BREAST CANCER RESEARCH (2018)
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
Violette Allouchery et al.
BREAST CANCER RESEARCH (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Current knowledge on exosome biogenesis and release
Nina Pettersen Hessvik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and-2) of neoadjuvant chemotherapy combined with bevacizumab
J-Y Pierga et al.
ANNALS OF ONCOLOGY (2017)
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Su-jin Yang et al.
GENE (2017)
UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer
Kuan Ning et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
Suzanne Jenkins et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Epithelial-to-mesenchymal transition in tumor progression
Elena Prieto-Garcia et al.
MEDICAL ONCOLOGY (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phosphoproteins in extracellular vesicles as candidate markers for breast cancer
I-Hsuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
Ru Wang et al.
ONCOTARGET (2017)
Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
Aiko Sueta et al.
ONCOTARGET (2017)
Clinical implications of ESR1 Mutations in Hormone ReceptorPositive Advanced Breast
Tomas Reinert et al.
FRONTIERS IN ONCOLOGY (2017)
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
B. A. S. Jaeger et al.
PLOS ONE (2017)
Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification
Shimeng Fang et al.
PLOS ONE (2017)
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging
Jose Angel Garcia-Saenz et al.
BMC CANCER (2017)
Increasing circulating exosomes-carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients
Teng Wang et al.
CANCER SCIENCE (2017)
Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection
Pyong-Gon Moon et al.
CLINICAL CANCER RESEARCH (2016)
Circulating tumor cells in breast cancer: applications in personalized medicine
Jin Sun Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation
Marta Tellez Gabriel et al.
CLINICAL CHEMISTRY (2016)
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion
Jeong-Eun Lee et al.
JOURNAL OF PROTEOMICS (2016)
Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients
Carolyn S. Hall et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Circulating tumor cells in breast cancer
Francois-Clement Bidard et al.
MOLECULAR ONCOLOGY (2016)
THE TUMOUR TRAIL LEFT IN BLOOD
Kelly Rae Chi
NATURE (2016)
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Jill M. Spoerke et al.
NATURE COMMUNICATIONS (2016)
Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
Pyong-Gon Moon et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
Kyung-A Hyun et al.
ONCOTARGET (2016)
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty et al.
JAMA ONCOLOGY (2016)
The Challenges of Detecting Circulating Tumor Cells in Sarcoma
Marta Tellez-Gabriel et al.
FRONTIERS IN ONCOLOGY (2016)
Plasma exosome microRNAs are indicative of breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2016)
Circulating Tumor DNA Outperforms Circulating Tumor Cells for KRAS Mutation Detection in Thoracic Malignancies
Maxim B. Freidin et al.
CLINICAL CHEMISTRY (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
Gaia Schiavon et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer
Marta Rodriguez et al.
ONCOTARGET (2015)
Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
Hongdo Do et al.
CLINICAL CHEMISTRY (2015)
The Plasma DNA Concentration as a Potential Breast Cancer Screening Marker
Orathai Tangvarasittichai et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2015)
Markers for the identification of late breast cancer recurrence
Ivana Sestak et al.
BREAST CANCER RESEARCH (2015)
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Alison S. Devonshire et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Early diagnostic value of survivin and its alternative splice variants in breast cancer
Salma Khan et al.
BMC CANCER (2014)
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
Sebastien Couraud et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Yong Wang et al.
NATURE (2014)
Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance
Xin Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles
Maria Amorim et al.
PROTEOMICS (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
Corinna Eichelser et al.
ONCOTARGET (2014)
Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer
Lindsey J. Graham et al.
JOURNAL OF CANCER (2014)
Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations
Guislaine Barriere et al.
ANNALS OF TRANSLATIONAL MEDICINE (2014)
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Asfar S. Azmi et al.
CANCER AND METASTASIS REVIEWS (2013)
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
Michael L. Marinovich et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hypoxic enhancement of exosome release by breast cancer cells
Hamish W. King et al.
BMC CANCER (2012)
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
M. L. Marinovich et al.
BREAST (2012)
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
Azeet Narayan et al.
CANCER RESEARCH (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy
Valentina Ciravolo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Evaluating the Clinical Utility of a Biomarker A Review of Methods for Estimating Health Impact
Mark J. Pletcher et al.
CIRCULATION (2011)
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage
Anne-Kathleen Rupp et al.
GYNECOLOGIC ONCOLOGY (2011)
HER2-Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis et al.
PLOS ONE (2011)
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
M. Pennant et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Clinical validity: Defining biomarker performance
Patrick M. M. Bossuyt
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells
Isabella Parolini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer
Heidi Schwarzenbach et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Induction of heat shock proteins in B-cell exosomes
A Clayton et al.
JOURNAL OF CELL SCIENCE (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
